New Therapeutic Targets for Cancer
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 2326
Special Issue Editor
Special Issue Information
Dear Colleagues,
As a result of the most recent societal and technological developments, the concept of cancer treatment is undergoing a fundamental change from empirical science to evidence-based medicine, and from cellular attack mode to targeted treatment mode. Drug targeted therapy, which applies targeted technology to precisely deliver drugs to the tumor area, and targeted therapy, which uses tumor-specific signaling or specific metabolic pathways, are some of the most popular themes in cancer research.
In this Special Issue, we are pleased to invite our colleagues to present their findings in the field of new therapeutic targets for cancer. In particular, articles reporting mechanisms of new molecular targets and novel targeting technologies are encouraged. This Special Issue aims to provide the most updated insights into targeted cancer therapy, and original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: the development of novel targeting approaches, new molecular targets, nano-targeting strategy, targeted regulation of tumor microenvironment, mechanism of anti-tumor drug targeting, anti-tumor chemotherapy drug targeting, and tumor immunotherapy targeting.
Prof. Dr. Lihua Luo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- targeted therapy
- drug targeted delivery
- molecular targets
- nanotechnology
- pharmaceuticals
- pharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
